Missed opportunities for HIV screening in pharmacies and retail clinics

Journal of Managed Care Pharmacy

Volumn 20, Issue 4, 2014, Pages 339-345

  Dugdale, Caitlin ^a   Zaller, Nickolas ^b   Bratberg, Jeffrey ^c   Berk, William ^b   Flanigan, Timothy ^d  

^a RHODE ISLAND HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

^c UNIVERSITY OF RHODE ISLAND   (United States)

^d MIRIAM HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH SERVICE; HEPATITIS C RAPID TEST; HIGH RISK POPULATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV RAPID TEST; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MEDICAID; MEDICARE; MEDICATION THERAPY MANAGEMENT; MEN WHO HAVE SEX WITH MEN; PATIENT COUNSELING; PHARMACIST; PHARMACY; REIMBURSEMENT; COUNSELING; EDUCATION; EPIDEMIOLOGY; HIV INFECTIONS; MASS SCREENING; ORGANIZATION AND MANAGEMENT; PROCEDURES; PROFESSIONAL STANDARD; UNITED STATES;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COMMUNITY PHARMACY SERVICES; COUNSELING; EDUCATION, PHARMACY, CONTINUING; HIV INFECTIONS; HUMANS; MASS SCREENING; PHARMACISTS; PROFESSIONAL ROLE; UNITED STATES;

EID: 84896930179     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2014.20.4.339     Document Type: Article

References (92)

1. Centers for Disease Control and Prevention. HIV surveillance-United States, 1981-2008. MMWR Morb Mortal Wkly Rep. 2011;60(21):689-93.
2. Centers for Disease Control and Prevention. Estimates of new HIV infections in the United States, 2007-2010. Updated December 19, 2013. Available at: http://www.cdc.gov/nchhstp/newsroom/2012/HIVIncidenceGraphics.html. Accessed February 3, 2013.
3. Hall HI, Holtgrave DR, Maulsby C. HIV transmission rates from persons living with HIV who are aware and unaware of their infection. AIDS. 2012;26(7):893-96.
4. Chen M, Rhodes PH, Hall IH, et al. Prevalence of undiagnosed HIV infection among persons aged = 13 years-National HIV Surveillance System, United States, 2005-2008. MMWR Morb Mortal Wkly Rep. 2012;61(Suppl):S57-S64.
5. Marks G, Crepaz N, Senterfitt JW, et al. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr. 2005;39(4):446-53.
6. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493-505.
7. Thompson MA, Aberg JA, Hoy JF, et al. Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. JAMA. 2012;308(4):387-402.
8. Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep. 2006;55(RR-14):1-17; quiz CE11-14.
9. U.S. Preventive Services Task Force. Screening for HIV. April 2013. Available at: http://www.uspreventiveservicestaskforce.org/uspstf/uspshivi. htm. Accessed February 3, 2014.
10. The White House Office of National AIDS Policy. National HIV/AIDS Strategy for the United States. July 2010. Available at: http://www.whitehouse. gov/sites/default/files/uploads/NHAS.pdf \. Accessed February 3, 2014.
11. Sabin CA, Smith CJ, Gumley H, et al. Late presenters in the era of highly active antiretroviral therapy: uptake of and responses to antiretroviral therapy. AIDS. 2004;18(16):2145-51.
12. Girardi E, Sabin CA, Monforte AD. Late diagnosis of HIV infection: epidemiological features, consequences and strategies to encourage earlier testing. J Acquir Immune Defic Syndr. 2007;46(Suppl 1):S3-S8.
13. Krentz HB, Gill MJ. The direct medical costs of late presentation (< 350/mm) of HIV infection over a 15-year period. AIDS Res Treat. 2012;2012:757135.
14. Mermin J, Fenton KA. The future of HIV prevention in the United States. JAMA. 2012;308(4):347-48.
15. Holtgrave DR, Hall HI, Wehrmeyer L, Maulsby C. Costs, consequences and feasibility of strategies for achieving the goals of the national HIV/AIDS strategy in the United States: a closing window for success? AIDS Behav. 2012;16(6):1365-72.
16. White DA, Cheung PT, Scribner AN, Frazee BW. A comparison of HIV testing in the emergency department and urgent care. J Emerg Med. 2010;39(4):521-28.
17. Centers for Disease Control and Prevention. Results of the expanded HIV testing initiative-25 jurisdictions, United States, 2007-2010. MMWR Morb Mortal Wkly Rep. 2011;60(24):805-10.
18. Centers for Disease Control and Prevention. High-impact HIV prevention: CDC's approach to reducing HIV infections in the United States. August 2011. Available at: http://www.cdc.gov/hiv/pdf/policies_NHPC_Booklet.pdf. Accessed February 3, 2014.
19. Liang TS, Erbelding E, Jacob CA, et al. Rapid HIV testing of clients of a mobile STD/HIV clinic. AIDS Patient Care STDS. 2005;19(4):253-57.
20. Merchant Medicine website. Available at: http://www.merchantmedicine. com/home.cfm. Accessed February 3, 2014.
21. Rudavsky R, Mehrotra A. Sociodemographic characteristics of communities served by retail clinics. J Am Board Fam Med. 2010;23(1):42-48.
22. Pollack CE, Armstrong K. The geographic accessibility of retail clinics for underserved populations. Arch Intern Med. 2009;169(10):945-49; discussion 950-53.
23. Pharmaceutical Care Management Association. PCMA: new study finds consumers have broad access to pharmacy choices in urban, suburban, and rural areas. May 1, 2007. Available at: http://www.pcmanet.org/2007-pressreleases/ pcma-new-study-finds-consumers-have-broad-access-to-pharmacychoices-in-urban-suburban-and-rural-areas. Accessed February 3, 2014.
24. Hirsch JD, Gonzales M, Rosenquist A, Miller TA, Gilmer TP, Best BM. Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries with HIV/AIDS. J Manag Care Pharm. 2011;17(3):213-23. Available at: http://www.amcp.org/WorkArea/ DownloadAsset.aspx?id=8973.
25. Deas C, McCree DH. Pharmacists and HIV/AIDS prevention: review of the literature. J Am Pharm Assoc (2003). 2010;50(3):411-15.
26. Myers JE, Bodash S, Cutler BH, Shepard CW. Acceptability of home self-test kits for HIV in New York City, 2006. Poster presented at: ID Week Conference; October 17-21, 2012; San Diego, CA. [abstract 121].
27. Katz DA, Golden, MR, Hughes JP, Farquhar C, Stekler JD. Acceptability and ease of use of home self-testing for HIV among MSM. Poster at: 19th Conference on Retroviruses and Opportunistic Infections; March 5-8, 2012; Seattle, WA.
28. Mehrotra A, Lave JR. Visits to retail clinics grew fourfold from 2007 to 2009, although their share of overall outpatient visits remains low. Health Aff (Millwood). 2012;31(9):2123-29.
29. McKinlay JB, Marceau LD. From cottage industry to a dominant mode of primary care: Stages in the diffusion of a health care innovation (retail clinics). Soc Sci Med. 2012;75(6):1134-41.
30. Deloitte Center for Health Solutions. Retail clinics: facts, trends, and implications. 2008. Available at: https://www.deloitte.com/assets/Dcom-UnitedStates/Local%20Assets/Documents/us_chs_RetailClinics_230708(1). pdf. Accessed February 3, 2014.
31. Howard P. Easy access, quality care: the role for retail health clinics in New York. Medical Progress Report, No. 12. 2011. Manhattan Institute for Policy Research. Available at: http://www.manhattan-institute.org/html/ mpr_12.htm. Accessed February 3, 2014.
32. Rudavsky R, Pollack CE, Mehrotra A. The geographic distribution, ownership, prices, and scope of practice at retail clinics. Ann Intern Med. 2009;151(5):315-20.
33. Thygeson M, Van Vorst KA, Maciosek MV, Solberg L. Use and costs of care in retail clinics versus traditional care sites. Health Aff (Millwood). 2008;27(5):1283-92.
34. Wang MC, Ryan G, McGlynn EA, Mehrotra A. Why do patients seek care at retail clinics, and what alternatives did they consider? Am J Med Qual. 2010;25(2):128-34.
35. Japsen B. More health clinic pop up inside retailers. New York Times, January 9, 2012. Available at: http://prescriptions.blogs.nytimes.com/2012/ 01/09/more-health-clinics-pop-up-inside-retailers/?_php=true&_type=blogs&_r=0. Accessed February 3, 2014.
36. Cassel CK. Retail clinics and drugstore medicine. JAMA. 2012;307(20):2151-52.
37. Appleby J. Walgreens becomes 1st retail chain to diagnose, treat chronic conditions. Kaiser Health News. April 4, 2013. Available at: http://www.kaiserhealthnews. org/stories/2013/april/04/walgreens-primary-care-services.aspx. Accessed February 3, 2014.
38. Frieden J. Retail clinics branch into chronic disease management. MedPage Today. March 25, 2010. Available at: http://www.medpagetoday. com/PracticeManagement/PracticeManagement/19207. Accessed February 3, 2014.
39. Uscher-Pines L, Harris KM, Burns RM, et al. The growth of retail clinics in vaccination delivery in the U.S. Am J Prev Med. 2012;43(1):63-66.
40. New York State Department of Health. HIV Testing -Chapter 308 of the Laws of 2010 HIV Testing Law Mandated Report. August 2012. Available at: http://www.health.ny.gov/diseases/aids/providers/testing/law/docs/chapter_308.pdf. Accessed November 3, 2012.
41. Mehrotra A, Wang MC, Lave JR, Adams JL, McGlynn EA. Retail clinics, primary care physicians, and emergency departments: a comparison of patients' visits. Health Aff (Millwood). 2008;27(5):1272-82.
42. Mehrotra A, Liu H, Adams JL, et al. Comparing costs and quality of care at retail clinics with that of other medical settings for 3 common illnesses. Ann Intern Med. 2009;151(5):321-28.
43. Gallegos A. Retail medicine: the cure for healthcare disparities? J Healthc Manag. 2007;52(4):227-34.
44. Laws M, Scott MK. The emergence of retail-based clinics in the United States: early observations. Health Aff (Millwood). 2008;27(5):1293-98.
45. Lee BY, Mehrotra A, Burns RM, Harris KM. Alternative vaccination locations: who uses them and can they increase flu vaccination rates? Vaccine. 2009;27(32):4252-56.
46. Meyerson BE, Ryder PT, von Hippel C, Coy K. We can do more than just sell the test: pharmacist perspectives about over-the-counter rapid HIV tests. AIDS Behav. 2013;17(6):2109-13.
47. Hogue MD, Grabenstein JD, Foster SL, Rothholz MC. Pharmacist involvement with immunizations: a decade of professional advancement. J Am Pharm Assoc (2003). 2006;46(2):168-79.
48. Weitzel KW, Goode JV. Implementation of a pharmacy-based immunization program in a supermarket chain. J Am Pharm Assoc (Wash). 2000;40(2):252-56.
49. Patwardhan PD, Chewning BA. Effectiveness of intervention to implement tobacco cessation counseling in community chain pharmacies. J Am Pharm Assoc (2003). 2012;52(4):507-14.
50. Dent LA, Harris KJ, Noonan CW. Tobacco interventions delivered by pharmacists: a summary and systematic review. Pharmacotherapy. 2007;27(7):1040-51.
51. Elias MN, Burden AM, Cadarette SM. The impact of pharmacist interventions on osteoporosis management: a systematic review. Osteoporos Int. 2011;22(10):2587-96.
52. Yuksel N, Majumdar SR, Biggs C, Tsuyuki RT. Community pharmacistinitiated screening program for osteoporosis: randomized controlled trial. Osteoporos Int. 2010;21(3):391-98.
53. Rudolph AE, Standish K, Amesty S, et al. A community-based approach to linking injection drug users with needed services through pharmacies: an evaluation of a pilot intervention in New York City. AIDS Educ Prev. 2010;22(3):238-51.
54. Zaller N, Jeronimo A, Bratberg J, Case P, Rich JD. Pharmacist and pharmacy staff experiences with non-prescription (NP) sale of syringes and attitudes toward providing HIV prevention services for injection drug users (IDUs) in Providence, RI. J Urban Health. 2010;87(6):942-53.
55. Chandra A, Malcolm N, 2nd, Fetters M. Practicing health promotion through pharmacy counseling activities. Health Promot Pract. 2003;4(1):64-71.
56. Snella KA, Canales AE, Irons BK, et al. Pharmacy-and communitybased screenings for diabetes and cardiovascular conditions in high-risk individuals. J Am Pharm Assoc (2003). 2006;46(3):370-77.
57. Kauffman Y, Nair V, Herist K, et al. HIV medication therapy management services in community pharmacies. J Am Pharm Assoc (2003). 2012;52(6):e287-91.
58. Rosenquist A, Best BM, Miller TA, Gilmer TP, Hirsch JD. Medication therapy management services in community pharmacy: a pilot programme in HIV specialty pharmacies. J Eval Clin Pract. 2010;16(6):1142-46.
59. Murphy P, Cocohoba J, Tang A, Pietrandoni G, Hou J, Guglielmo BJ. Impact of HIV-specialized pharmacies on adherence and persistence with antiretroviral therapy. AIDS Patient Care STDS. 2012;26(9):526-31.
60. Kibicho J, Owczarzak J. Pharmacists' strategies for promoting medication adherence among patients with HIV. J Am Pharm Assoc (2003). 2011;51(6):746-55.
61. Hirsch JD, Rosenquist A, Best BM, Miller TA, Gilmer TP. Evaluation of the first year of a pilot program in community pharmacy: HIV/AIDS medication therapy management for Medi-Cal beneficiaries. J Manag Care Pharm. 2009;15(1):32-41. Available at: http://www.amcp.org/WorkArea/ DownloadAsset.aspx?id=8066.
62. Kibicho J, Owczarzak J. A patient-centered pharmacy services model of HIV patient care in community pharmacy settings: a theoretical and empirical framework. AIDS Patient Care STDS. 2012;26(1):20-28.
63. Cocohoba JM, Murphy P, Pietrandoni G, et al. Improved antiretroviral refill adherence in HIV-focused community pharmacies. J Am Pharm Assoc (2003). 2012;52(5):e67-73.
64. Amesty S, Blaney S, Crawford ND, Rivera AV, Fuller C. Pharmacy staff characteristics associated with support for pharmacy-based HIV testing. J Am Pharm Assoc (2003). 2012;52(4):472-79.
65. Walgreens. Walgreens HIV Centers of Excellence pharmacies now top 500 nationwide in areas most impacted by HIV/AIDS. Press release. November 10, 2011. Available at: http://news.walgreens.com/article_display. cfm?article_id=5502. Accessed February 3, 2014.
66. Gorostiza I, Elizondo López de Landache I, Braceras Izagirre L. [HIV/ AIDS screening program in community pharmacies in the Basque Country (Spain)]. Gac Sanit. 2013;27(2):164-66. [Article in Spanish]
67. Calderon Y, Cowan E, Rhee JY, Brusalis C, Leider J. Counselor-based rapid HIV testing in community pharmacies. AIDS Patient Care STDS. 2013;27(8):467-73.
68. Division of HIV/AIDS Prevention. Annual report 2011: accelerating progress, investing for impact. Centers for Disease Control and Prevention. March 2012. Available at: http://www.cdc.gov/hiv/pdf/policies_DHAP_ AnnualReport.pdf. Accessed February 3, 2014.
69. Centers for Disease Control and Prevention. Press release: Innovative CDC effort expands HIV testing into pharmacies. NCHHSTP Newsroom. June 26, 2012. Available at: http://www.cdc.gov/nchhstp/newsroom/ NHTDPressRelease2012.html. Accessed February 3, 2014.
70. Kuehn BM. CDC pilot program will offer free rapid HIV tests through pharmacies. JAMA. 2012;308(4):327.
71. Smith SR, Golin CE, Reif S. Influence of time stress and other variables on counseling by pharmacists about antiretroviral medications. Am J Health Syst Pharm. 2004;61(11):1120-29.
72. Beatty SJ, McCormick KM, Beale DJ, et al. Current trends in outpatient pharmacy services and billing. J Am Pharm Assoc (2003). 2012;52(2):154-60.
73. Benjamin R. Support letter from U.S. Surgeon General. December 14, 2011 Available at: http://www.accp.com/docs/positions/misc/Support_ Letter_from_US_Surgeon_General.pdf. Accessed February 3, 2014.
74. Lutnick A, Case P, Kral AH. Injection drug users' perspectives on placing HIV prevention and other clinical services in pharmacy settings. J Urban Health. 2012;89(2):354-64.
75. National Public Radio. A stop at the drugstore now includes an HIV test. July 19, 2012. Available at: http://www.npr.org/2012/07/19/157041278/stopat-the-drugstore-now-includes-hiv-test. Accessed February 3, 2014.
76. U.S. Food and Drug Administration. FDA approves first over-the-counter home-use rapid HIV test. July 3, 2012. Available at: http://www.fda.gov/ NewsEvents/Newsroom/PressAnnouncements/ucm310542.htm. Accessed February 3, 2014.
77. OraQuick. The first in-home oral HIV test. Available at: http://www. oraquick.com/Healthcare-Professionals/The-First-In-Home-Oral-HIV-Test. Accessed February 3, 2014.
78. Myers JE, El-Sadr WM, Zerbe A, Branson BM. Rapid HIV self-testing: long in coming but opportunities beckon. AIDS. 2013;27(11):1687-95.
79. Greacen T, Friboulet D, Blachier A, et al. Internet-using men who have sex with men would be interested in accessing authorised HIV self-tests available for purchase online. AIDS Care. 2013;25(1):49-54.
80. Sharma A, Sullivan PS, Khosropour CM. Willingness to fake a free home HIV test and associated factors among Internet-using men who have sex with men. J Int Assoc Physicians AIDS Care (Chic). 2011;10(6):357-64.
81. Mackellar DA, Hou SI, Whalen CC, et al. Reasons for not HIV testing, testing intentions, and potential use of an over-the-counter rapid HIV test in an internet sample of men who have sex with men who have never tested for HIV. Sex Transm Dis. 2011;38(5):419-28.
82. An Q, Prejean J, McDavid Harrison K, Fang X. Association between community socioeconomic position and HIV diagnosis rate among adults and adolescents in the United States, 2005 to 2009. Am J Public Health. 2013;103(1):120-26.
83. Centers for Disease Control and Prevention. Characteristics associated with HIV infection among heterosexuals in urban areas with high AIDS prevalence-24 cities, United States, 2006-2007. MMWR Morb Mortal Wkly Rep. 2011;60(31):1045-49.
84. Paltiel AD, Pollack HA. Price, performance, and the FDA approval process: the example of home HIV testing. Med Decis Making. 2010;30(2):217-23.
85. Paltiel AD, Walensky RP. Home HIV testing: good news but not a game changer. Ann Intern Med. 2012;157(10):744-46.
86. Thrun MW, Gardner EM, Rietmeijer CA. Home HIV testing: if you build it, will they come? AIDS. 2013;27(11):1825-26.
87. Marks G, Gardner LI, Craw J, Crepaz N. Entry and retention in medical care among HIV-diagnosed persons: a meta-analysis. AIDS. 2010;24(17):2665-78.
88. Centers for Disease Control and Prevention. Vital signs: HIV prevention through care and treatment-United States. MMWR Morb Mortal Wkly Rep. 2011;60(47):1618-23.
89. Gardner LI, Metsch LR, Anderson-Mahoney P, et al. Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care. AIDS. 2005;19(4):423-31.
90. OraSure Technologies. Final advisory committee briefing materials. Available for public release: OraQuick In-Home HIV Test. May 15, 2012 Available at: http://www.fda.gov/downloads/AdvisoryCommittees/ CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/BloodProductsAdvisoryCommittee/UCM303652.pdf. Accessed February 3, 2014.
91. Arnold C. At-home HIV test poses dilemmas and opportunities. Lancet. 2012;380(9847):1045-46.
92. CVS. MinuteClinic Services and Costs. Available at: http://www.minuteclinic. com/services/. Accessed February 3, 2014.